Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

RYOIX vs SHPAX overlap: 22% of top holdings shared

Bottom line

How much do RYOIX and SHPAX overlap?

22% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 20.1% of RYOIX's assets and 25.3% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.

RYOIX holds far more positions (74 vs 29), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

RYOIXSHPAX
Weight overlap (top 25)22%
Shared holdings6
Weight in shared holdings20.1%25.3%
Total positions7429
Expense ratio1.38%3%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings RYOIX and SHPAX have in common

Holding% of RYOIX% of SHPAXOverlap
Amgen Inc AMGN5.05%5.04%5.04%
Gilead Sciences Inc GILD4.49%3.94%3.94%
Vertex Pharmaceuticals Inc VRTX4.32%3.36%3.36%
Regeneron Pharmaceuticals Inc REGN2.93%3.93%2.93%
United Therapeutics Corp UTHR1.72%6.17%1.72%
Incyte Corp INCY1.62%2.89%1.62%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in RYOIX

  1. Abbvie Inc — 8.17%
  2. Revolution Medicines Inc — 2.48%
  3. Alnylam Pharmaceuticals Inc — 2.36%
  4. Beone Medicines Ltd — 2.17%
  5. Moderna Inc — 2.15%
  6. Biogen Inc — 2.13%
  7. Natera Inc — 2.12%
  8. Royalty Pharma Plc — 2.01%
  9. Illumina Inc — 1.94%
  10. Insmed Inc — 1.79%
  11. Guardant Health Inc — 1.72%
  12. Roivant Sciences Ltd — 1.66%
  13. Viatris Inc — 1.55%
  14. Neurocrine Biosciences Inc — 1.52%
  15. Argenx Se — 1.48%

Only in SHPAX

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. Mckesson Corp — 4.90%
  4. Lantheus Holdings Inc — 4.64%
  5. Exelixis Inc — 4.55%
  6. Novartis Ag — 4.50%
  7. Cencora Inc — 4.33%
  8. Johnson & Johnson — 3.91%
  9. National Healthcare Corp — 3.72%
  10. Merck & Company Inc — 3.63%
  11. Cigna Group (the) — 3.63%
  12. Medpace Holdings Inc — 3.37%
  13. Intuitive Surgical Inc — 3.14%
  14. Bristol-myers Squibb Company — 3.07%
  15. Stryker Corp — 2.40%

Asset mix

Asset typeRYOIXSHPAX
Stocks99.6%99.0%
Cash & short-term funds0.6%1.6%
Repurchase agreements0.6%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryRYOIXSHPAX
US85.8%86.1%
IE2.7%8.4%
CH3.3%4.5%
GB3.2%—
BM1.7%—
DK0.9%1.6%
NL1.5%—
DE1.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do RYOIX and SHPAX overlap?
About 22% by weight. 6 securities appear in both funds' top 25 holdings; they make up 20.1% of RYOIX's assets and 25.3% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do RYOIX and SHPAX have in common?
The largest shared holdings are Amgen Inc, Gilead Sciences Inc, Vertex Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, United Therapeutics Corp.
Should I own both RYOIX and SHPAX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, RYOIX or SHPAX?
RYOIX is broader, with 74 positions versus 29 for SHPAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.